I ensure that our growing fleet of PET cameras provides excellent image quality and accuracy. MSK currently has 13 cameras, with four more soon to follow. My responsibilities include overseeing the quality assurance and calibration procedures. I also establish the data acquisition and reconstruction protocols for studies involving both standard and exotic radionuclides.
My research interests include pharmacokinetic modeling, parametric image generation, PET data acquisition modeling and reconstruction, data mining, and radionuclide therapy. In addition to consulting on and performing data analysis for several ongoing clinical trials, I have received funding from the National Cancer Institute to develop a novel form of radionuclide therapy. This treatment, an Auger electron-emitting androgen analogue, will be used for people with castration-resistant prostate cancer.